Reference
Terashima T, et al. Successful second conversion surgery after trastuzumab deruxtecan for recurrent HER2-positive gastric cancer. Clinical Journal of Gastroenterology 16: No. 3, Jun 2023. Available from: URL: https://www.springer.com/journal/12328
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1965, 45 (2023). https://doi.org/10.1007/s40278-023-43013-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-43013-z